vessels with perivascular infiltration of the involved area (Heal and Kent, 1953) . The blood clotting mechanism of these patients reveals defects similar to those seen with the so-called hypercoagulable state and purpura fulminans has been included in the growing list of conditions characterized by Disseminated Intravascular Coagulation (DIC). Little (1959) has suggested the descriptive eponym, Post-infectious Intravascular Thrombosis with Gan- grene. On the assumption that thrombosis and consequent consumption of clotting factors is the basic defect in purpura fulminans, heparin with its antithrombin activity has been used in management. four hours from the onset of therapy she was less toxic with a normal temperature and the oozing of blood from the mouth had ceased. Seventy-two hours from the onset of therapy, coagulation studies, urinanalysis, blood urea, SGPT activity, serum protein electrophoresis and X-rays of the chest, right femur and leg, were normal (Table 1) . Heparin therapy was discontinued on the eighth day and 24 hr later, surgical debridement of the lesions of the right thigh was performed. There was extensive sloughing and necrosis involving the skin, subcutaneous tissues and muscle layers. Coagulation studies before and after surgery were normal and the patient tolerated the procedure well without excessive bleeding. Histological examination of the removed tissues showed thrombosis of small blood vessels with perivascular infiltration, damage of vascular endothelium and tissue necrosis (Fig. 3) (RodriguezErdman, 1965) . These deficiencies in the clotting factors have been repeatedly shown in recent studies with purpura fulminans (Little, 1959; Glass, 1962; Bauhasin, 1964; Allen, 1966; Antley and McMillan, 1967; Dudgeon et al., 1971) . Our patient had prolongation of bleeding time, clotting time (more than 1 hr), prothrombin time (2j min) and partial thromboplastin time (6 min) and a low platelet count 50,000/mm3) with a deficiency of fibrinogen (20 mg/ 100 ml) were found. Although facilities for factor V and VIII assays were not available, the pattern of tests is regarded adequate for the evaluation of DIC (Antley and McMillan, 1967, Dudgeon et al., 1971) .
Heparin is regarded as the therapeutic agent of choice in the management of purpura fulminans (Rodriguez-Erdman, 1965; Antley and McMillan, 1967) and successful treatment has been reported by Little (1959) and others (Glass, 1962; Antley and McMillan, 1967; Hattersley, 1970; Dudgeon et al., 1971 ). We were able to correct the coagulation McMillan, 1967; Hattersley, 1970) .
Corticosteroids have been used in the treatment of purpura fulminans, although they seem not to be indicated since they potentiate the Schwartzman phenomenon. In practice they are found to provide no clinical benefit to successful therapy (Crawford and Riddler, 1959; van Creveld et al., 1965) . Treatment with blood and fibrinogen has been advocated and although this mode of therapy is theoretically contraindicated since it supplies substrates for intravascular thrombosis, the results vary from further deterioration to complete recovery (van der Horst, 1962; Bauhasin, 1964) .
Low molecular weight dextran has been used successfully and the beneficial effects are attributed to coating of vessel walls and the blood elements with prevention of sludging (Patterson et al., 1965; Smith, 1967) . Morse, Rowe and Hartigan (1966) treated two cases by using antifibrinolytic agent (Epsilon aminocaproic acid) and both recovered. Excessive plasma fibrinolytic activity is seen with DIC and in these cases it is regarded as secondary or defensive fibrinolysin with a protective role. Antifibrinolytic agents may be used in purpura fulminans, if it can be demonstrated that fibrinolytic activity is primary, since its use with secondary fibrinolysin consequent to DIC can be dangerous (Ratnoff, 1969; Seabaugh et al., 1971; Rodriguez-Erdman et al., 1971; McMillan, Weiss and Johnson, 1972) .
Hyperbaric oxygen has been used with temporary improvement to save borderline necrotic tissues (Kuzemko and Loder, 1970; Dudgeon et al., 1971) and vitamins K, C and rutin have also been employed (Chambers et al., 1952) .
Anaemia is frequently associated with purpura fulminans and is usually attributed to external loss and extravasation. This patient had severe anaemia which was secondary to blood loss and a microangiopathic haemolytic process. The evidence for this type of anaemia was the grossly distorted and fragmented erythrocytes, normoblastaemia and a high reticulocyte count. In our review of the literature on purpura fulminans, its association with microangiopathic haemolytic anaemia is mentioned only twice (Hollingsworth and Mohler, 1968; Dudgeon et al., 1971) . However, if carefully sought, it may be determined more frequently in view of the known association with conditions characterized by intravascular coagulation and fibrin deposition (Brain, Dacie and Hourihane, 1962) .
This patient died in spite of the fact that the clotting abnormality was corrected and surgical debridement satisfactorily tolerated. Septic death in purpura fulminans has been reported and secondary infections of the skin lesions by both Gram-negative and Gram-positive organisms have also been observed (Hollingsworth and Mohler, 1968; Dudgeon et al., 1971) . The nature of this enhanced susceptibility to infection remains unknown. 
